Clinical trial NCT06316011: MCG for Risk Stratifications of Patients With Chest Pain
Official title: Magnetocardiography in the Identification and Risk Stratification of Patients With Acute Chest Pian
Study type: OBSERVATIONAL
Overall status: RECRUITING
Conditions: Acute Coronary Syndrome
Lead sponsor: Qilu Hospital of Shandong University
Sponsor class: OTHER
Collaborators: name: Chongqing Emergency Medical Center
name: Weifang People's Hospital
name: Linyi People's Hospital
name: Weihai Central Hospital
name: Jining First People's Hospital
name: The First Affiliated Hospital with Nanjing Medical University
name: Second Affiliated Hospital, School of Medicine, Zhejiang University
name: First Affiliated Hospital Xi'an Jiaotong University
name: First People's Hospital of Hangzhou
name: Guangdong Provincial Hospital of Traditional Chinese Medicine
name: Qianfoshan Hospital
name: Heze Municipal Hospital
name: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
First posted: 2024-03-18
Enrollment: 3620
Sex: ALL
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: patient who suffers from cardiogenic chest pain suspected with acute coronary syndrome （ACS）.

Brief summary: This prospective cohort study is aimed at identification and risk stratification of patients who have symptoms of acute chest pain suspected with acute coronary syndrome （ACS） using Magnetocardiography （MCG）.


Eligibility criteria: Inclusion Criteria:

* Those with suspected ACS who presented with symptoms of acute chest pain.
* Signed informed consent.

Exclusion Criteria:

* Those with known structural heart disease such as cardiomyopathy and valvular disease;
* Those with atrial fibrillation, supraventricular tachycardia, atrioventricular block and other arrhythmias that have not returned to normal;
* Those who have chest pain with known pulmonary embolism or aortic coarctation;
* Those who are thought to be incapable of completing the MCG examination by an attending physician (or physician with higher qualifications) due to unstable clinical conditions, metal implants, etc;
* Those who are unable to perform magnetocardiography examinations due to claustrophobia, etc., or those who fail to receive magnetocardiography examination;
* Those with malignant tumors;
* Pregnant or lactating women.
* Those with acute or critical illnesses of other systems, such as acute or severe respiratory illnesses, marked abnormalities in liver function or kidney function.

Primary outcomes:
measure: Efficacy of MCG for the detection and risk stratification in high-risk patients with chest pain
timeFrame: from the date of enrollment until the date of discharge, up to 30 days
measure: Efficacy of MCG for the detection and risk stratification in low-risk patients with chest pain
timeFrame: from the date of enrollment until the date of discharge, up to 30 days
Secondary outcomes:
Other outcomes:
Locations:
city: Jinan
country: China
facility: Qilu Hospital of Shandong University
state: Shandong
Study officials:
affiliation: Qliu Hospital of Shandong University
name: Yuguo Chen, Professor
role: PRINCIPAL_INVESTIGATOR
References: